Utah Medical Products, Inc.
UTMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$225.52M
Close$
$90.90
26.1% upside
Current Fair Value
26.1% upsideUndervalued by 26.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $225.52 Million |
|---|---|
| Enterprise Value | $138.19 Million |
| Dividend Yield | $1.24 (1.74%) |
| Earnings per Share | $3.41 |
| Beta | 0.36 |
| Outstanding Shares | 3,184,000 |
Return
| Return on Equity | 8.59% |
|---|---|
| Return on Assets | 8.42% |
| Return on Invested Capital | 9.50% |
Valuation & Multiples
| P/E Ratio | 22 |
|---|---|
| PEG | -185.21 |
| Price to Sales | 6.55 |
| Price to Book Ratio | 1.9 |
| Enterprise Value to Revenue | 3.83 |
| Enterprise Value to EBIT | 11.88 |
| Enterprise Value to Net Income | 13 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 23, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 22, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 16.07%▼ 52.40% |
|---|---|
| Total Invested | $35.33M▼ 74.85% |
| Investors Holding | 45▼ 74.00% |
ESG Score
No data
About Utah Medical Products, Inc.
CEO: Kevin Cornwell Utah Medical Products, Inc. with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hund...